Relapsed Small Cell Lung Cancer (SCLC)
1 clinical trials · Condition
◉ Watch Relapsed Small Cell Lung Cancer (SCLC)
| Record | Firm | Date |
|---|---|---|
| AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors (NCT02511795) | AstraZeneca | 2015-08-06 |
Track Relapsed Small Cell Lung Cancer (SCLC) automatically
Every clearance here is in the API, with alerts when new ones post.